GFAP and serum lipopolysaccharide activity: With dioscin treatment, the number of GFAP immuno-reactive astrocyte decreased greatly (Fig. 5C), indicating that dioscin may have a potential role in the regulation of neuro-inflammation and treatment of endotoxemia induced acute neuro-inflammation.